Literature DB >> 21462259

Focal cortical and subcortical atrophy in early Parkinson's disease.

Sule Tinaz1, Maureen G Courtney, Chantal E Stern.   

Abstract

Neurodegeneration in clinically manifest Parkinson's disease affects the substantia nigra pars compacta, and gradually spreads to the limbic cortices and the neocortex. We used MRI imaging coupled with automated surface reconstruction and segmentation methods to examine cortical thickness and subcortical volumes in nondemented, early-stage Parkinson's disease patients compared to matched healthy control participants. These methods, which have been previously used to document cortical thickness changes in patients with Alzheimer's disease and Huntington's disease but not Parkinson's disease, use MR signal intensity information and the geometric constraints of the cortical and subcortical structures for an accurate tissue classification. Parkinson's disease patients were matched to the control group in psychomotor processing speed and executive functioning, but showed higher anxiety state scores. Our results demonstrated focal cortical thinning in the Parkinson's disease group in the orbitofrontal cortex, ventrolateral prefrontal cortex, and occipito-parietal areas. Subcortically, striatal volume loss was noted. These results demonstrate that both cortical and subcortical structural changes occur at relatively early stages of the disease, and are discussed in terms of the emotional dysregulation that occurs early on in patients with Parkinson's disease.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 21462259      PMCID: PMC4502575          DOI: 10.1002/mds.23453

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

3.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

4.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

7.  Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.

Authors:  Dao-Ying Geng; Yu-Xin Li; Chi-Shing Zee
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

8.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

9.  Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy.

Authors:  Christian Brenneis; Klaus Seppi; Michael F Schocke; Jörg Müller; Elisabeth Luginger; Sylvia Bösch; Wolfgang N Löscher; Christian Büchel; Werner Poewe; Gregor K Wenning
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

10.  Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.

Authors:  J Mimi Boer Castelo; Maureen G Courtney; Rebecca J Melrose; Chantal E Stern
Journal:  Arch Neurol       Date:  2007-09
View more
  47 in total

1.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

2.  Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging.

Authors:  Koji Kamagata; Andrew Zalesky; Taku Hatano; Ryo Ueda; Maria Angelique Di Biase; Ayami Okuzumi; Keigo Shimoji; Masaaki Hori; Karen Caeyenberghs; Christos Pantelis; Nobutaka Hattori; Shigeki Aoki
Journal:  Hum Brain Mapp       Date:  2017-05-04       Impact factor: 5.038

3.  Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment.

Authors:  Carlo Tessa; Claudio Lucetti; Marco Giannelli; Stefano Diciotti; Michele Poletti; Sabrina Danti; Filippo Baldacci; Claudio Vignali; Ubaldo Bonuccelli; Mario Mascalchi; Nicola Toschi
Journal:  Hum Brain Mapp       Date:  2014-01-22       Impact factor: 5.038

4.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

5.  Demonstration of Early Cognitive Impairment in Parkinson's Disease with Visual P300 Responses.

Authors:  Gülin Özmüş; Deniz Yerlikaya; Arife Gökçeoğlu; Derya Durusu Emek Savaş; Raif Çakmur; Beril Dönmez Çolakoğlu; Görsev G Yener
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

6.  Cerebrospinal fluid levels of chromogranin A in the treatment-naïve early stage Parkinson's disease: a pilot study.

Authors:  Michaela Kaiserová; Hana Přikrylová Vranová; David Stejskal; Kateřina Menšíková; Petr Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2013-04-16       Impact factor: 3.575

7.  Perceptual, cognitive, and personality rigidity in Parkinson's disease.

Authors:  Mirella Díaz-Santos; Bo Cao; Arash Yazdanbakhsh; Daniel J Norton; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2015-01-30       Impact factor: 3.139

8.  Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis.

Authors:  E Mak; N Bergsland; M G Dwyer; R Zivadinov; N Kandiah
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-31       Impact factor: 3.825

9.  Automated MRI parcellation of the frontal lobe.

Authors:  Marin E Ranta; Min Chen; Deana Crocetti; Jerry L Prince; Krish Subramaniam; Bruce Fischl; Walter E Kaufmann; Stewart H Mostofsky
Journal:  Hum Brain Mapp       Date:  2013-07-29       Impact factor: 5.038

10.  Gender-based analysis of cortical thickness and structural connectivity in Parkinson's disease.

Authors:  Santosh K Yadav; Nagarajan Kathiresan; Suyash Mohan; Georgia Vasileiou; Anup Singh; Deepak Kaura; Elias R Melhem; Rakesh K Gupta; Ena Wang; Francesco M Marincola; Arijitt Borthakur; Mohammad Haris
Journal:  J Neurol       Date:  2016-08-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.